Ponatinix

Ponatinix uses and dosage

Ponatinix (Ponatinib), generic Iclusig is a prescription medicine used to treat a type of blood cancer which is chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) for whom no other tyrosine kinase inhibitor (TKI) medicines are received. Ponatinix manufactured by Beacon Pharma Ltd. in Bangladesh. Ponatinib has to take 45mg orally once a day with or without food.

Ponatinix side effects

The most common adverse reactions of Ponatinib are: Headache, dizziness, constipation, or loss of appetite.

Originator brand

Iclusig by Ariad Pharma

Made by

Beacon pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.